CN112724096A - Preparation method of S-4-phenyl-2-oxazolidinone - Google Patents

Preparation method of S-4-phenyl-2-oxazolidinone Download PDF

Info

Publication number
CN112724096A
CN112724096A CN202110192333.9A CN202110192333A CN112724096A CN 112724096 A CN112724096 A CN 112724096A CN 202110192333 A CN202110192333 A CN 202110192333A CN 112724096 A CN112724096 A CN 112724096A
Authority
CN
China
Prior art keywords
compound
oxazolidinone
phenyl
preparation
finished
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110192333.9A
Other languages
Chinese (zh)
Inventor
马军
张�林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gansu Beishengkangde Pharmaceutical Co ltd
Original Assignee
Gansu Beishengkangde Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gansu Beishengkangde Pharmaceutical Co ltd filed Critical Gansu Beishengkangde Pharmaceutical Co ltd
Priority to CN202110192333.9A priority Critical patent/CN112724096A/en
Publication of CN112724096A publication Critical patent/CN112724096A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/22Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention discloses a preparation method of S-4-phenyl-2-oxazolidinone, which comprises the following steps: reducing the compound 8 by potassium borohydride under an acidic condition to obtain a compound 9, and then cyclizing the compound 9 and diethyl carbonate under an alkaline condition to obtain a compound 10, namely the(s) -4-phenyl-2-oxazolidinone. The preparation method disclosed by the invention has the advantages that the raw materials are easy to obtain, the reaction conditions are mild, the steps are simple, flammable and explosive reagents are not used, the preparation method is suitable for large-scale industrial production, and the safety is high; and the reaction yield is higher and the cost is lower. Has wide application prospect.

Description

Preparation method of S-4-phenyl-2-oxazolidinone
Technical Field
The invention belongs to the technical field of synthesis of chemical intermediates of organic synthesis, and particularly relates to a preparation method of S-4-phenyl-2-oxazolidinone.
Background
The S-4-phenyl-2-oxazolidinone is a common organic medical intermediate, such as a key material of a lipid-lowering drug namely ezetimibe, and can also be used for synthesizing a pesticide intermediate and auxiliary macromolecules.
Figure 780834DEST_PATH_IMAGE001
The currently disclosed preparation method of S-4-phenyl-2-oxazolidinone requires three steps for synthesis, and the synthetic route is as follows:
Figure 166816DEST_PATH_IMAGE002
in the method, the synthesis steps are more, the reaction in the first step is violent, the control is not suitable, the yield of the final product is low, and the large-scale production cannot be realized.
In view of the good market prospects of S-4-phenyl-2-oxazolidinone, there is a need to develop new preparation methods for S-4-phenyl-2-oxazolidinone.
Disclosure of Invention
The invention aims to solve the technical problem of providing a preparation method of S-4-phenyl-2-oxazolidinone aiming at the defects in the prior art, and the preparation method is mild in reaction conditions, simple in steps and capable of obtaining by one-step reduction.
In order to solve the technical problems, the invention adopts the following technical scheme:
a preparation method of S-4-phenyl-2-oxazolidinone comprises the following specific processes:
a. reducing the compound 8 and a reducing agent potassium borohydride or sodium borohydride under an acidic condition to obtain a compound 9;
wherein compound 8 has the following structural formula:
Figure 415395DEST_PATH_IMAGE003
wherein compound 9 has the following structural formula:
Figure DEST_PATH_IMAGE004
b. and cyclizing the compound 9 and diethyl carbonate under an alkaline condition to obtain the S-4-phenyl-2-oxazolidinone.
The molar ratio of the compound 8 to the reducing agent in the step a is 1: 2.0-2.6.
The acidic condition is an inorganic acid solution condition, and the alkaline condition is an inorganic alkali solution condition.
The inorganic acid is sulfuric acid, and the inorganic base is potassium carbonate.
The molar ratio of the compound 8 to the inorganic acid in the step a is 1:0.8-1.
The synthesis reaction of the step a is specifically as follows:
uniformly adding 10 batches of potassium borohydride and a compound 8 into a tetrahydrofuran system, wherein the mass ratio of the compound 8 to the tetrahydrofuran is 1:4.2, and slowly dropwise adding sulfuric acid at the temperature of 27-30 ℃, wherein the molar ratio of the compound 8 to the sulfuric acid is 1: 0.8-1.2; after the addition is finished, the system is kept at the temperature of 30-40 ℃ for 4h, and the reaction is finished; cooling the system to 10 ℃, dropwise adding a sodium hydroxide aqueous solution with the mass concentration of 20% into the system, wherein the mass ratio of the compound 8 to the sodium hydroxide aqueous solution is 1:2.5, refluxing the system at 90-100 ℃ for 2h, stirring for reaction for 30min, naturally cooling to 65-70 ℃, standing for layering; the organic phase was collected, dried and concentrated under reduced pressure to give intermediate compound 9.
The synthesis reaction of the step b is specifically as follows:
adding potassium carbonate and a compound 9 into a toluene solvent system, wherein the mass ratio of the compound 9 to toluene is 1: 8, heating to 60-70 ℃ and stirring; the control system is that diethyl carbonate is slowly dripped at 70-75 ℃, wherein the molar ratio of the compound 9 to the diethyl carbonate is 1: 1, stirring and reacting for 1.5h under heat preservation after dripping is finished, distilling at normal pressure after heat preservation is finished, and cooling the system to below 40 ℃ after distillation is finished; adding a cyclization agent inorganic base potassium carbonate into a nitrogen replacement system in 5 batches under the protection of nitrogen, stirring and heating after the addition is finished, keeping the temperature at 90-100 ℃, refluxing for 30min, and cooling to below 40 ℃; wherein the molar ratio of compound 9 to potassium carbonate is 1: 0.2; acetic acid is dropwise added, and the mass ratio of the compound 9 to the acetic acid is 1: 0.15, and then dropwise adding water, wherein the mass ratio of the compound 9 to the water is 1: 3.3; cooling the system to below 10 ℃ after the addition, stirring for 1h, and filtering to obtain white solid S-4-phenyl-2-oxazolidinone.
The synthetic route is as follows:
Figure 279446DEST_PATH_IMAGE005
the positive progress effects of the invention are as follows: the S-4-phenyl-2-oxazolidinone prepared by the invention has high reaction yield (about 83%), simple preparation method, easily obtained used raw materials, mild reaction conditions, simple steps, one-step reduction, easy operation, environmental friendliness, suitability for large-scale industrial production, high safety and wide application prospect.
Detailed Description
The following provides a detailed description of the preferred embodiments of the present invention.
Example 1
A process for the preparation of compound 9, wherein the reducing agent is potassium borohydride:
Figure DEST_PATH_IMAGE006
evenly dividing 10 batches of potassium borohydride (9.3 g) and a compound 8 (10 g) and putting the mixture into a tetrahydrofuran (42 g) system, and slowly dropwise adding sulfuric acid (8.0 g) at the temperature of 27 ℃; after the addition is finished, the system is kept at the temperature of 30 ℃ for 3h, and the reaction is finished; cooling the system to 10 ℃, dropwise adding 25g of sodium hydroxide aqueous solution with the mass concentration of 20% into the system, refluxing the system at 100 ℃ for 2h, stirring for 30min, naturally cooling to 70 ℃, standing and layering; the organic phase was collected, dried and concentrated under reduced pressure to give the intermediate compound 9 in 85% yield.
Example 2
Preparation of compound 9, wherein the reducing agent is potassium borohydride:
Figure 359397DEST_PATH_IMAGE007
evenly dividing 10 batches of potassium borohydride (93 g) and compound 8 (100 g) into tetrahydrofuran (420 g) of the system, and slowly dropwise adding sulfuric acid (80.0 g) at the temperature of the system being 30 ℃; after the addition is finished, the system is kept at the temperature of 35 ℃ for 3h, and the reaction is finished; cooling the system to 10 ℃, dropwise adding 250g of sodium hydroxide aqueous solution with the mass concentration of 20% into the system, refluxing the system at 95 ℃ for 2h, stirring for 30min, naturally cooling to 70 ℃, standing and layering; the organic phase was collected, dried and concentrated under reduced pressure to give the intermediate compound 9 in 85% yield.
Example 3
Preparation of compound 9, wherein the reducing agent is potassium borohydride:
Figure DEST_PATH_IMAGE008
evenly dividing 10 batches of potassium borohydride (80 g) and compound 8 (100 g) into tetrahydrofuran (420 g) of the system, and slowly dropwise adding sulfuric acid (80.0 g) at the temperature of 27 ℃; after the addition is finished, the system is kept at 40 ℃ for 3h, and the reaction is finished; cooling the system to 10 ℃, dropwise adding 250g of sodium hydroxide aqueous solution with the mass concentration of 20% into the system, refluxing the system at 90 ℃ for 2h, stirring for 30min, naturally cooling to 65 ℃, standing and layering; the organic phase was collected, dried and concentrated under reduced pressure to give intermediate compound 9 in 80% yield.
Example 4
Preparation of compound 9, wherein the reducing agent is sodium borohydride:
Figure 637319DEST_PATH_IMAGE009
sodium borohydride (6.6 g) and a compound (8) (10 g) are alternately put into tetrahydrofuran (42 g) of a system, and sulfuric acid (9.6 g) is slowly added dropwise at the temperature of the system being 30 ℃; after the addition is finished, the system is kept at 40 ℃ for 3h, and the reaction is finished; cooling the system to 10 ℃, dropwise adding 25g of sodium hydroxide aqueous solution with the mass concentration of 20% into the system, refluxing the system at 100 ℃ for 2h, stirring for 30min, naturally cooling to 65 ℃, standing and layering; the organic phase was collected, dried and concentrated under reduced pressure to give the intermediate compound 9 in 85% yield.
Example 5
Preparation of compound 9, wherein the reducing agent is sodium borohydride:
Figure DEST_PATH_IMAGE010
sodium borohydride (66 g) and a compound (8) (100 g) are alternately put into tetrahydrofuran (420 g) of a system, and sulfuric acid (80 g) is slowly added dropwise when the temperature of the system is 28 ℃; after the addition, the system is kept at the temperature of 30-40 ℃ for 3h, and the reaction is finished; cooling the system, dropwise adding 250g of sodium hydroxide aqueous solution with the mass concentration of 20% into the system, refluxing the system at 100 ℃ for 2h, stirring for 30min, naturally cooling to 70 ℃, standing and layering; the organic phase was collected, dried and concentrated under reduced pressure to give the intermediate compound 9 in 85% yield.
Example 6
Preparation of compound 10:
Figure 169932DEST_PATH_IMAGE011
potassium carbonate (8.22 g) and compound 9 (10 g) were added to toluene (80 g) as a solvent, and the mixture was heated to 70 ℃ and stirred; slowly dripping 8.6g of diethyl carbonate at 75 ℃ in the system, preserving the temperature and stirring for reaction for 1.5h after dripping, carrying out normal pressure distillation after preserving the temperature, allowing an azeotrope of toluene and water to flow out when the internal temperature is 95 ℃, and cooling the system to below 40 ℃ after distillation; after replacing the system with nitrogen, adding potassium carbonate (2 g) in batches under the protection of nitrogen, stirring and heating after the addition is finished; refluxing at 100 deg.C for 30min, and cooling to below 40 deg.C; acetic acid (1.5 g) and water (33 g) were added dropwise; after the addition, the temperature of the system is reduced to below 10 ℃, the mixture is stirred for 1h, and the S-4-phenyl-2-oxazolidinone compound 10 is obtained after filtration, with the yield of 83 percent.
Example 7
Preparation of compound 10:
Figure DEST_PATH_IMAGE012
potassium carbonate (82.2 g) and compound 9 (100 g) were added to toluene (800 g) as a solvent, and the mixture was heated to 60 ℃ and stirred; slowly dripping 86g of diethyl carbonate at the temperature of 70 ℃ in the system, preserving the temperature, stirring and reacting for 1.5h after dripping, distilling at normal pressure after preserving the temperature, wherein an azeotrope of toluene and water flows out when the internal temperature is 95 ℃, and cooling the system to below 40 ℃ after distilling; after replacing the system with nitrogen, adding potassium carbonate (20 g) in batches under the protection of nitrogen, stirring and heating after the addition is finished; keeping the temperature at 90 ℃ for refluxing for 30min, and then cooling to below 40 ℃; dropwise adding acetic acid (15 g) and water (330 g); after the addition, the temperature of the system is reduced to below 10 ℃, the mixture is stirred for 1h, and the S-4-phenyl-2-oxazolidinone compound 10 is obtained after filtration, with the yield of 83 percent.

Claims (7)

1. A preparation method of S-4-phenyl-2-oxazolidinone is characterized by comprising the following specific processes:
a. reducing the compound 8 and a reducing agent potassium borohydride or sodium borohydride under an acidic condition to obtain a compound 9;
wherein compound 8 has the following structural formula:
Figure DEST_PATH_IMAGE001
wherein compound 9 has the following structural formula:
Figure 742031DEST_PATH_IMAGE002
b. and cyclizing the compound 9 and diethyl carbonate under an alkaline condition to obtain the S-4-phenyl-2-oxazolidinone.
2. A process for the preparation of S-4-phenyl-2-oxazolidinone as defined in claim 1, wherein: the molar ratio of the compound 8 to the reducing agent in the step a is 1: 2.0-2.6.
3. A process for the preparation of S-4-phenyl-2-oxazolidinone as defined in claim 1 or 2, wherein: the acidic condition is an inorganic acid solution condition, and the alkaline condition is an inorganic alkali solution condition.
4. A process for the preparation of S-4-phenyl-2-oxazolidinone as defined in claim 3, wherein: the inorganic acid is sulfuric acid, and the inorganic base is potassium carbonate.
5. A process for the preparation of S-4-phenyl-2-oxazolidinone as claimed in claim 1 or 4, wherein: the molar ratio of the compound 8 to the inorganic acid in the step a is 1: 0.8-1.2.
6. A process for the preparation of S-4-phenyl-2-oxazolidinone as defined in claim 5, wherein: the synthesis reaction of the step a is specifically as follows:
uniformly adding 10 batches of potassium borohydride and a compound 8 into a tetrahydrofuran system, wherein the mass ratio of the compound 8 to the tetrahydrofuran is 1:4.2, and slowly dropwise adding sulfuric acid at the temperature of 27-30 ℃, wherein the molar ratio of the compound 8 to the sulfuric acid is 1: 0.8-1.2; after the addition is finished, the system is kept at the temperature of 30-40 ℃ for 4h, and the reaction is finished; cooling the system to 10 ℃, dropwise adding a sodium hydroxide aqueous solution with the mass concentration of 20% into the system, wherein the mass ratio of the compound 8 to the sodium hydroxide aqueous solution is 1:2.5, refluxing the system at 90-100 ℃ for 2h, stirring for reaction for 30min, naturally cooling to 65-70 ℃, standing for layering; the organic phase was collected, dried and concentrated under reduced pressure to give intermediate compound 9.
7. A process for the preparation of S-4-phenyl-2-oxazolidinone as defined in claim 6, wherein: the synthesis reaction of the step b is specifically as follows:
adding potassium carbonate and a compound 9 into a toluene solvent system, wherein the mass ratio of the compound 9 to toluene is 1: 8, heating to 60-70 ℃ and stirring; the control system is that diethyl carbonate is slowly dripped at 70-75 ℃, wherein the molar ratio of the compound 9 to the diethyl carbonate is 1: 1, stirring and reacting for 1.5h under heat preservation after dripping is finished, distilling at normal pressure after heat preservation is finished, and cooling the system to below 40 ℃ after distillation is finished; adding a cyclization agent inorganic base potassium carbonate into a nitrogen replacement system in 5 batches under the protection of nitrogen, stirring and heating after the addition is finished, keeping the temperature at 90-100 ℃, refluxing for 30min, and cooling to below 40 ℃; wherein the molar ratio of compound 9 to potassium carbonate is 1: 0.2; acetic acid is dropwise added, and the mass ratio of the compound 9 to the acetic acid is 1: 0.15, and then dropwise adding water, wherein the mass ratio of the compound 9 to the water is 1: 3.3; cooling the system to below 10 ℃ after the addition, stirring for 1h, and filtering to obtain white solid S-4-phenyl-2-oxazolidinone.
CN202110192333.9A 2021-02-20 2021-02-20 Preparation method of S-4-phenyl-2-oxazolidinone Pending CN112724096A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110192333.9A CN112724096A (en) 2021-02-20 2021-02-20 Preparation method of S-4-phenyl-2-oxazolidinone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110192333.9A CN112724096A (en) 2021-02-20 2021-02-20 Preparation method of S-4-phenyl-2-oxazolidinone

Publications (1)

Publication Number Publication Date
CN112724096A true CN112724096A (en) 2021-04-30

Family

ID=75596787

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110192333.9A Pending CN112724096A (en) 2021-02-20 2021-02-20 Preparation method of S-4-phenyl-2-oxazolidinone

Country Status (1)

Country Link
CN (1) CN112724096A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104151258A (en) * 2014-08-26 2014-11-19 江苏万年长药业有限公司 Method and apparatus for recycling tetrahydrofuran solvent during reduction reaction of L-phenylglycinol
CN104744390A (en) * 2015-03-19 2015-07-01 南京师范大学 Preparation method of ezetimibe internmediate ketone
US20150336943A1 (en) * 2013-01-07 2015-11-26 Pierre Fabre Medicament Novel benzodioxane-piperidine derivatives and their therapeutic applications for treating neuropsychiatric disorders
CN108484419A (en) * 2018-05-04 2018-09-04 江苏万年长药业有限公司 The improved method of hydrolysis process in a kind of L- benzene glycinol preparation process

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150336943A1 (en) * 2013-01-07 2015-11-26 Pierre Fabre Medicament Novel benzodioxane-piperidine derivatives and their therapeutic applications for treating neuropsychiatric disorders
CN104151258A (en) * 2014-08-26 2014-11-19 江苏万年长药业有限公司 Method and apparatus for recycling tetrahydrofuran solvent during reduction reaction of L-phenylglycinol
CN104744390A (en) * 2015-03-19 2015-07-01 南京师范大学 Preparation method of ezetimibe internmediate ketone
CN108484419A (en) * 2018-05-04 2018-09-04 江苏万年长药业有限公司 The improved method of hydrolysis process in a kind of L- benzene glycinol preparation process

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ATSUSHI ABIKO ET AL.: "An Improved, Convenient Procedure for Reduction of Amino Acids to Aminoalcohols:Use of NaBH4-H2SO4" *
DANIELE ZAMPIERI ET AL.: "Computer-assis ted de sign, synthesis , binding and cytotoxicity assessmen ts of new 1-(4-(aryl(methyl ) amino)butyl)-heterocyclic sigma 1 ligands" *

Similar Documents

Publication Publication Date Title
CN107805203A (en) A kind of preparation method of hexamethylene diamine
CN112979498A (en) Preparation method of 3-fluoro-4-trifluoromethyl benzonitrile
CN112500361B (en) Preparation method of (S) -4-phenyl-2-oxazolidinone
CN107098822A (en) A kind of preparation method for preparing the hydroxy acetophenone of 3 amino of Pranlukast key intermediate 2
CN112724096A (en) Preparation method of S-4-phenyl-2-oxazolidinone
CN104860857B (en) Methylthiosemicarbazone synthesis technique
CN110590702B (en) Novel method for preparing 2-mercaptobenzothiazole
CN102942532A (en) Preparation method of 1,4,7,10-tetraazadodecane
CN105566257A (en) Industrial preparation method of acetyl tetrahydrofuran with high optical purity
CN106478422B (en) A kind of preparation method of paranitrophenylacetic acid
CN108129414B (en) Preparation method of mosapride citrate intermediate
CN113149899A (en) Method for preparing 4-trifluoromethyl nicotinic acid
CN108329218B (en) Preparation method of (R) -epinephrine
CN101367762B (en) Preparation method of midbody 7-chloroquinaldine
CN112898152A (en) Preparation method of ethoxy diethyl methylene malonate
WO2009011551A2 (en) Process for the efficient preparation of 3-hydroxy pyrrolidine and derivatives thereof
CN115850232B (en) Preparation method and application of flupentixol EP impurity H
CN112300059B (en) Preparation method of PF-06651600 intermediate
CN112321535B (en) Preparation method of immaric acid or hydrochloride thereof
CN114605234B (en) Preparation method of trimethyl orthoacetate
CN111303220B (en) Preparation method of D-glucosamine sulfate
CN114315866B (en) Synthesis method of levamisole hydrochloride
CN116969823A (en) Preparation method of squaric acid intermediate
CN111039838B (en) Preparation method of 3-acetylmercapto-2-methylpropanoic acid
CN114539184A (en) Preparation method of cariprazine intermediate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210430